GSA Capital Partners’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,306
| Closed | -$112K | – | 2031 |
|
|
2025
Q1 | $112K | Buy |
+15,306
| New | +$112K | 0.01% | 1485 |
|
|
2024
Q4 | – | Sell |
-126,681
| Closed | -$1.1M | – | 1903 |
|
|
2024
Q3 | $1.1M | Buy |
+126,681
| New | +$1.1M | 0.08% | 417 |
|
|
2024
Q2 | – | Sell |
-28,741
| Closed | -$262K | – | 1921 |
|
|
2024
Q1 | $262K | Sell |
28,741
-218,162
| -88% | -$1.99M | 0.02% | 1291 |
|
|
2023
Q4 | $1.1M | Buy |
246,903
+13,321
| +6% | +$59.4K | 0.09% | 343 |
|
|
2023
Q3 | $733K | Buy |
233,582
+114,629
| +96% | +$360K | 0.06% | 567 |
|
|
2023
Q2 | $614K | Buy |
+118,953
| New | +$614K | 0.06% | 616 |
|
|
2022
Q3 | – | Sell |
-127,978
| Closed | -$514K | – | 1774 |
|
|
2022
Q2 | $514K | Buy |
127,978
+70,358
| +122% | +$283K | 0.08% | 485 |
|
|
2022
Q1 | $285K | Buy |
+57,620
| New | +$285K | 0.04% | 928 |
|
|
2019
Q4 | – | Sell |
-11,222
| Closed | -$34K | – | 1637 |
|
|
2019
Q3 | $34K | Buy |
+11,222
| New | +$34K | ﹤0.01% | 1333 |
|
|
2018
Q2 | – | Sell |
-15,600
| Closed | -$102K | – | 1858 |
|
|
2018
Q1 | $102K | Buy |
+15,600
| New | +$102K | 0.01% | 1528 |
|
|
2015
Q3 | – | Sell |
-12,412
| Closed | -$261K | – | 1946 |
|
|
2015
Q2 | $261K | Buy |
+12,412
| New | +$261K | 0.01% | 1682 |
|